• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

EVVA 队列研究:HIV 感染者中肛门和宫颈型别特异性人乳头瘤病毒流行率、持续性和细胞学结果。

The EVVA Cohort Study: Anal and Cervical Type-Specific Human Papillomavirus Prevalence, Persistence, and Cytologic Findings in Women Living With HIV.

机构信息

Department of Family Medicine.

Chronic Viral Illness Service, McGill University Health Centre (MUHC).

出版信息

J Infect Dis. 2017 Aug 15;216(4):447-456. doi: 10.1093/infdis/jix273.

DOI:10.1093/infdis/jix273
PMID:28931234
Abstract

BACKGROUND

The risk of anal cancer due to high-risk human papillomavirus (HR-HPV) is higher in women living with human immunodeficiency virus (HIV) than in the general population. We present findings of cervical and anal HPV and cytologic tests at baseline in the EVVA cohort study and HPV persistence data 6 months after baseline.

METHODS

Semiannual visits included questionnaires, chart reviews, cervical/anal cytologic and cervical/anal HPV testing for 2 years. Genotyping for 36 HPV genotypes was performed using the Roche Linear Array HPV genotyping test.

RESULTS

A total of 151 women living with HIV were recruited. At baseline, 75% had anal HPV, 51% had anal HR-HPV, 50% had cervical HPV, and 29% had cervical HR-HPV. Anal HPV-16 and HPV-51 were more frequent in women born in Canada (31% and 29%, respectively, compared with ≤16% for other women). Most anal HR-HPV types detected at 6 months (57%-93%) were persistent from baseline. Findings of anal cytologic tests were abnormal for 37% of women.

CONCLUSIONS

Anal HPV is highly prevalent in women living with HIV, and type distribution varies by place of birth. High-resolution anoscopy was indicated in more than one third of results. As anal cancer is potentially preventable, these important findings need to be considered when selecting the best approach for anal cancer screening programs.

摘要

背景

感染人类免疫缺陷病毒(HIV)的女性发生人乳头瘤病毒(HPV)相关肛门癌的风险高于普通人群。我们报告了 EVVA 队列研究中基线时宫颈和肛门 HPV 及细胞学检测的结果,以及基线后 6 个月的 HPV 持续感染数据。

方法

每半年进行一次随访,包括问卷调查、病历回顾、宫颈/肛门细胞学检查以及宫颈/肛门 HPV 检测,共随访 2 年。采用罗氏线性阵列 HPV 基因分型检测对 36 种 HPV 基因型进行基因分型。

结果

共招募了 151 名 HIV 感染者。基线时,75%的女性存在肛门 HPV 感染,51%存在肛门高危型 HPV 感染,50%存在宫颈 HPV 感染,29%存在宫颈高危型 HPV 感染。在加拿大出生的女性中,HPV-16 和 HPV-51 的感染率更高(分别为 31%和 29%,而其他女性的感染率≤16%)。6 个月时检测到的大多数肛门高危型 HPV 类型(57%-93%)均为持续性感染。37%的女性肛门细胞学检查结果异常。

结论

HIV 感染者中肛门 HPV 感染非常普遍,且其分布类型因出生地而异。超过三分之一的结果需要进行高分辨率肛门镜检查。由于肛门癌是一种潜在可预防的疾病,因此在选择肛门癌筛查方案时,需要考虑这些重要发现。

相似文献

1
The EVVA Cohort Study: Anal and Cervical Type-Specific Human Papillomavirus Prevalence, Persistence, and Cytologic Findings in Women Living With HIV.EVVA 队列研究:HIV 感染者中肛门和宫颈型别特异性人乳头瘤病毒流行率、持续性和细胞学结果。
J Infect Dis. 2017 Aug 15;216(4):447-456. doi: 10.1093/infdis/jix273.
2
Human papillomavirus infection and cytologic abnormalities of the anus and cervix among HIV-infected women in the study to understand the natural history of HIV/AIDS in the era of effective therapy (the SUN study).在接受有效治疗的时代了解艾滋病毒/艾滋病自然史的研究(SUN 研究)中,感染人类乳头瘤病毒和肛门及宫颈细胞学异常的 HIV 感染女性。
Sex Transm Dis. 2011 Apr;38(4):253-9. doi: 10.1097/OLQ.0b013e3181f70253.
3
Prevalence of cervical, oral, and anal human papillomavirus infection in women living with HIV in Denmark - The SHADE cohort study.丹麦 HIV 感染者中宫颈、口腔和肛门人乳头瘤病毒感染的流行情况 - SHADE 队列研究。
J Clin Virol. 2018 Aug;105:64-71. doi: 10.1016/j.jcv.2018.05.010. Epub 2018 May 25.
4
Interest of cytology combined with Xpert HPV and Anyplex II HPV28 Detection human papillomavirus (HPV) typing: differential profiles of anal and cervical HPV lesions in HIV-infected patients on antiretroviral therapy.细胞学检查联合 Xpert HPV 和 Anyplex II HPV28 检测人乳头瘤病毒 (HPV) 分型在抗逆转录病毒治疗的 HIV 感染患者中的应用:肛门和宫颈 HPV 病变的差异特征。
HIV Med. 2018 Nov;19(10):698-707. doi: 10.1111/hiv.12661. Epub 2018 Jul 30.
5
Prevalence of and Risk Factors for Anal Oncogenic Human Papillomavirus Infection Among HIV-Infected Women in France in the Combination Antiretroviral Therapy Era.法国组合型抗反转录病毒疗法时代感染人类免疫缺陷病毒的女性肛门致癌型人乳头瘤病毒感染的流行率和危险因素。
J Infect Dis. 2016 May 1;213(9):1455-61. doi: 10.1093/infdis/jiv751. Epub 2015 Dec 21.
6
Prevalence and Incidence of Anal and Cervical High-Risk Human Papillomavirus (HPV) Types Covered by Current HPV Vaccines Among HIV-Infected Women in the SUN Study.在 SUN 研究中,感染 HIV 的女性中当前 HPV 疫苗涵盖的肛门和宫颈高危型人乳头瘤病毒(HPV)的流行率和发生率。
J Infect Dis. 2018 Apr 23;217(10):1544-1552. doi: 10.1093/infdis/jiy087.
7
Anal and Cervical High-Risk Human Papillomavirus Genotyping in Women With and Without Genital Neoplasia.女性生殖道肿瘤患者与非肿瘤患者的肛门及宫颈高危型人乳头瘤病毒基因分型检测。
J Low Genit Tract Dis. 2018 Apr;22(2):115-119. doi: 10.1097/LGT.0000000000000368.
8
Analysis of the prevalence of human papillomavirus and abnormal anal cytology in women at risk.分析高危女性人群中人类乳头瘤病毒感染和异常肛门细胞学的流行情况。
J Obstet Gynaecol. 2021 Oct;41(7):1139-1144. doi: 10.1080/01443615.2020.1845630. Epub 2021 Jan 16.
9
Anal human papillomavirus (HPV) prevalences and factors associated with abnormal anal cytology in HIV-infected women in an urban cohort from Rio de Janeiro, Brazil.巴西里约热内卢一个城市队列中感染艾滋病毒女性的肛门人乳头瘤病毒(HPV)流行率及与肛门细胞学异常相关的因素。
AIDS Patient Care STDS. 2015 Jan;29(1):4-12. doi: 10.1089/apc.2014.0166.
10
High prevalence and incidence of HPV-related anal cancer precursor lesions in HIV-positive women in the late HAART era.高效抗逆转录病毒治疗(HAART)晚期时代,HIV 阳性女性中与 HPV 相关的肛门癌前病变的高患病率和发病率。
Enferm Infecc Microbiol Clin (Engl Ed). 2018 Nov;36(9):555-562. doi: 10.1016/j.eimc.2017.10.014. Epub 2017 Dec 6.

引用本文的文献

1
Primary Anal Cancer Screening Results From 381 Women With Human Immunodeficiency Virus.原发性肛门癌筛查结果:381 名人类免疫缺陷病毒感染女性。
J Infect Dis. 2023 Apr 18;227(8):932-938. doi: 10.1093/infdis/jiac398.
2
Identifying risk factors for prevalent anal human papillomavirus type 16 infection in women living with HIV.确定人乳头瘤病毒 16 型在 HIV 感染者女性中流行感染的风险因素。
PLoS One. 2022 May 19;17(5):e0268521. doi: 10.1371/journal.pone.0268521. eCollection 2022.
3
Human papillomavirus genotype concordance between Anyplex II HPV28 and linear array HPV genotyping test in anogenital samples.
肛门生殖器样本中Anyplex II HPV28与线性阵列HPV基因分型检测之间的人乳头瘤病毒基因型一致性
J Med Virol. 2022 Jun;94(6):2824-2832. doi: 10.1002/jmv.27605. Epub 2022 Jan 28.
4
Screening strategies for the detection of anal high-grade squamous intraepithelial lesions in women living with HIV.针对 HIV 感染者女性肛门高级别鳞状上皮内病变的筛查策略。
AIDS. 2020 Dec 1;34(15):2249-2258. doi: 10.1097/QAD.0000000000002694.
5
Acceptability of anal cancer screening tests for women living with HIV in the EVVA study.接受度的肛门癌筛查试验妇女生活与艾滋病毒在 evva 研究。
Curr Oncol. 2020 Feb;27(1):19-26. doi: 10.3747/co.27.5401. Epub 2020 Feb 1.
6
Persistence of cervical high-risk human papillomavirus in women living with HIV in Denmark - the SHADE.丹麦 HIV 感染者中宫颈高危型人乳头瘤病毒的持续性 - SHADE 研究。
BMC Infect Dis. 2019 Aug 22;19(1):740. doi: 10.1186/s12879-019-4377-5.
7
Prevalence of and Risk Factors for Anal High-grade Squamous Intraepithelial Lesions in Women Living with Human Immunodeficiency Virus.人免疫缺陷病毒感染者肛门高级别鳞状上皮内病变的流行状况及其危险因素。
Clin Infect Dis. 2020 Apr 10;70(8):1701-1707. doi: 10.1093/cid/ciz408.
8
Cervical determinants of anal HPV infection and high-grade anal lesions in women: a collaborative pooled analysis.女性肛门 HPV 感染和高级别肛门病变的宫颈决定因素:协作汇总分析。
Lancet Infect Dis. 2019 Aug;19(8):880-891. doi: 10.1016/S1473-3099(19)30164-1. Epub 2019 Jun 13.